{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:09:19Z","timestamp":1789585759566,"version":"build-2803163510"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Similar pathogenesis makes Corona Virus Disease 2019 (COVID-19) associated with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and gouty arthritis (GA), and it is possible to introduce common drugs for the treatment of RA, AS and GA into the treatment of COVID-19. That is, \u201chomotherapy for heteropathy\u201d, especially cytokine inhibitors. But little is known about the specific link between the diseases. In addition, \u201cnew use of old drugs\u201d is an important short-term strategy for the treatment of COVID-19. Cepharanthine (CEP), a monomer component of traditional Chinese medicine (TCM), is mainly used in the treatment of leukopenia and has recently been proved to have a good therapeutic effect on COVID-19, but its specific molecular mechanism has not been clearly explained. The purpose of this work is to explore the common targets and signaling pathways among COVID-19, RA, AS, and GA by means of network pharmacology (NP), and to infer the potential mechanism of CEP in the treatment of COVID-19.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Firstly, SwissTargetPrediction was used to predict the targets of CEP, and the pathogenic targets of COVID-19, RA, AS and GA were searched in GeneCards, OMIM, TTD, PharmGKB database and literature, respectively. Then, the protein interaction network of CEP and COVID-19 cross targets and the common targets of COVID-19, RA, AS and GA was constructed. Cytosscape 3.7.2 software was used to construct CEP-common targets-signaling pathways-COVID-19 network, module function analysis, gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG). Finally, the molecular docking of hub targets and CEP was carried out by AutoDock software.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The results showed that the common targets of the four diseases were tumor necrosis factor (TNF), interleukin (IL)-6 and IL-1\u03b2, and involved Coronavirus disease, IL-17 signaling pathway and TNF signaling pathway. CEP has a good binding force with AKT Serine\/Threonine Kinase 1 (AKT1), phosphatidylinositol 3-kinase (PIK3) CA, PIK3CD and Angiotensin-converting enzyme 2 (ACE2), and plays a role in the treatment of COVID-19 by regulating PI3K-Akt signaling pathway, Relaxin signaling pathway, VEGF signaling pathway and HIF-1 signaling pathway.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Therefore, this study not only confirmed the potential mechanism of CEP in the treatment of COVID-19 at the molecular level, but also found that TNF and IL-17 inhibitors, which are commonly used in the treatment of RA, AS and GA, may also affect the treatment of COVID-19, which provides new clues and theoretical basis for the rapid discovery of effective therapeutic drugs for COVID-19.<\/jats:p>","DOI":"10.3389\/fphar.2022.960267","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:07:28Z","timestamp":1658498848000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19"],"prefix":"10.3389","volume":"13","author":[{"given":"Ping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-065X.2008.00615.x","article-title":"Is interleukin-1 a good or bad \u2018guy\u2019 in tumor immunobiology and immunotherapy?","volume":"222","author":"Apte","year":"2008","journal-title":"Immunol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s11033-022-07166-x","article-title":"Blocking TNF signaling may save lives in COVID-19 infection","volume":"49","author":"Ablamunits","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1756-185X.2012.01820.x","article-title":"Patterns of angiotensin converting enzyme insertion\/deletion gene polymorphism among an Egyptian cohort of patients with rheumatoid arthritis","volume":"16","author":"Ahmed","year":"2013","journal-title":"Int. J. Rheum. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","article-title":"OMIM.org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders","volume":"43","author":"Amberger","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B5","first-page":"1367","article-title":"Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart","volume":"152","author":"Bani","year":"1998","journal-title":"Am. J. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(12)61424-X","article-title":"Tofacitinib (CP-690, 550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: A randomised phase 3 trial","volume":"381","author":"Burmester","year":"2013","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"104791","DOI":"10.1016\/j.phrs.2020.104791","article-title":"Could IL-17 represent a new therapeutic target for the treatment and\/or management of COVID-19-related respiratory syndrome?","volume":"156","author":"Casillo","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jama.2020.1623","article-title":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside wuhan, China","volume":"323","author":"Chang","year":"2020","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e42714","DOI":"10.1371\/journal.pone.0042714","article-title":"Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: The additional involvement of iNOS","volume":"7","author":"Chow","year":"2012","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: A database of reactions, pathways and biological processes","volume":"39","author":"Croft","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s0008-6363(03)00348-1","article-title":"Toll-like receptors in cardiovascular diseases","volume":"60","author":"de Kleijn","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/13813455.2019.1703005","article-title":"Genetic polymorphisms of ACE I\/D, IL-1\u03b2 G > A and IL-4 VNTR among Egyptian subjects with rheumatoid arthritis","volume":"128","author":"Elshazli","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model","volume":"133","author":"Fan","year":"2020","journal-title":"Chin. Med. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: Faraway, so close","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8841911","DOI":"10.1155\/2021\/8841911","article-title":"HIF-1, the warburg effect, and macrophage\/microglia polarization potential role in COVID-19 pathogenesis","volume":"2021","author":"Ferraro","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 global rheumatology alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with covid-19 pneumonia","volume":"385","author":"Guimar\u00e3es","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: The next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B25","first-page":"2107","article-title":"Significant association between insertion\/deletion polymorphism of the angiotensin-convertig enzyme gene and ankylosing spondylitis","volume":"18","author":"Inan\u0131r","year":"2012","journal-title":"Mol. Vis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"B27","first-page":"1075","article-title":"Clinical efficacy of cepharanthin(r)for radiotherapy-induced leukopenia - a nationwide, multicenter, and observational study","volume":"43","author":"Kanamori","year":"2016","journal-title":"Gan Kagaku Ryoho."},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s13577-021-00484-5","article-title":"PI3K\/AKT signaling pathway: A possible target for adjuvant therapy in COVID-19","volume":"34","author":"Khezri","year":"2021","journal-title":"Hum. Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/tid.13404","article-title":"SARS\u2010CoV2 and immunosuppression: A double\u2010edged sword","volume":"22","author":"Lai","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/bib\/bbaa387","article-title":"Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus","volume":"22","author":"Li","year":"2021","journal-title":"Brief. Bioinform."},{"key":"B34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","article-title":"Traditional Chinese medicine network pharmacology: Theory, methodology and application","volume":"11","author":"Li","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bj.2020.04.007","article-title":"COVID-19: The first documented coronavirus pandemic in history","volume":"43","author":"Liu","year":"2020","journal-title":"Biomed. J."},{"key":"B36","unstructured":"2019-novel coronavirus (2019-nCoV) infections trigger an exaggerated cytokine response aggravating lung injury\n            LiuY.\n            ZhangC.\n            HuangF.\n            YangY.\n            WangF.\n            YuanJ.\n          10.12074\/202002.000182020"},{"key":"B37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fphar.2016.00250","article-title":"Commentary: IL-17 in chronic inflammation: From discovery to targeting","volume":"7","author":"Maione","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1007\/BF03354073","article-title":"The effect of relaxin on myocardial ischaemia-reperfusion injury and histamine release in vitro and in vivo","volume":"45","author":"Masini","year":"1996","journal-title":"Inflamm. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1165\/rcmb.2017-0265OC","article-title":"IL-17 plays a role in respiratory syncytial virus\u2013induced lung inflammation and emphysema in elastase and LPS-injured mice","volume":"58","author":"Mebratu","year":"2018","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"102367","DOI":"10.1016\/j.isci.2021.102367","article-title":"Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment","volume":"24","author":"Ohashi","year":"2021","journal-title":"iScience"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/S1567-5769(01)00127-8","article-title":"Protection of T cells from radiation-induced apoptosis by Cepharanthin\u00ae","volume":"1","author":"Oyaizu","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s43440-020-00132-z","article-title":"Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19","volume":"72","author":"Rogosnitzky","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: A database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.1002\/jcp.27660","article-title":"miR\u201015a\u20105p suppresses inflammation and fibrosis of peritoneal mesothelial cells induced by peritoneal dialysis via targeting VEGFA","volume":"234","author":"Shang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"640782","DOI":"10.3389\/fphar.2021.640782","article-title":"Broad anti-viral capacities of lian-hua-qing-wen capsule and jin-hua-qing-Gan granule and rational use against COVID-19 based on literature mining","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00404-017-4586-3","article-title":"Stimulation of chemokines in human endometrial stromal cells by tumor necrosis factor-\u03b1 and interferon-\u03b3 is similar under apoptotic and non-apoptotic conditions","volume":"297","author":"Spratte","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: From gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B49","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: The vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","article-title":"HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19","volume":"6","author":"Tian","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/thoraxjnl-2018-211846","article-title":"Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of \u03b2-catenin","volume":"74","author":"Wang","year":"2019","journal-title":"Thorax"},{"key":"B53","doi-asserted-by":"publisher","first-page":"D1031","DOI":"10.1093\/nar\/gkz981","article-title":"Therapeutic target database 2020: Enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3389\/fphar.2020.01013","article-title":"Turning the tide: Natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/323819a0","article-title":"Tumour necrosis factors \u03b1 and \u03b2 inhibit virus replication and synergize with interferons","volume":"323","author":"Wong","year":"1986","journal-title":"Nature"},{"key":"B57","unstructured":"WHO Novel coronavirus (2019-nCoV) situation reports2020"},{"key":"B58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jcb.1155","article-title":"Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines","volume":"82","author":"Wu","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.jaad.2020.10.084","article-title":"If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19","volume":"84","author":"Xu","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0171628","DOI":"10.1371\/journal.pone.0171628","article-title":"Natural formulas and the nature of formulas: Exploring potential therapeutic targets based on traditional Chinese herbal formulas","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS ONE"},{"key":"B64","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2","volume":"202","author":"Zhao","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat. Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"153336","DOI":"10.1016\/j.phymed.2020.153336","article-title":"Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW","volume":"79","author":"Zheng","year":"2020","journal-title":"Phytomedicine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"","journal-title":"Lancet"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.960267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:07:34Z","timestamp":1658498854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.960267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":67,"alternative-id":["10.3389\/fphar.2022.960267"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.960267","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"960267"}}